Come up with a name for your new list and we'll add to it:
Advantagene raised a round of funding on April 20, 2016. Investors include
National Securities Corporation.
Advantagene is a Boston-area privately held biopharmaceutical company focused on preventing the recurrence and progression of cancer through the use of novel therapeutics in oncology and immunotherapy…